Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

This study has been completed.
Sponsor:
Information provided by:
Hospital de Calella
ClinicalTrials.gov Identifier:
NCT00415090
First received: December 19, 2006
Last updated: October 30, 2008
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)